Join

Compare · ACHV vs IDXX

ACHV vs IDXX

Side-by-side comparison of Achieve Life Sciences Inc. (ACHV) and IDEXX Laboratories Inc. (IDXX): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both ACHV and IDXX operate in Biotechnology: In Vitro & In Vivo Diagnostic Substances (Health Care), so they compete in similar markets.
  • IDXX is the larger of the two at $44.27B, about 78.7x ACHV ($562.6M).
  • Over the past year, ACHV is up 46.3% and IDXX is up 8.1% - ACHV leads by 38.2 points.
  • ACHV has been more active in the news (10 items in the past 4 weeks vs 5 for IDXX).
  • IDXX has more recent analyst coverage (23 ratings vs 8 for ACHV).
PerformanceACHV+46.27%IDXX+8.09%
2025-06-09+0.00%2026-06-08
MetricACHVIDXX
Company
Achieve Life Sciences Inc.
IDEXX Laboratories Inc.
Price
$5.49+7.13%
$561.97-0.07%
Market cap
$562.6M
$44.27B
1M return
+14.39%
-1.85%
1Y return
+46.27%
+8.09%
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Exchange
NASDAQ
NASDAQ
IPO
1991
News (4w)
10
5
Recent ratings
8
23
ACHV

Achieve Life Sciences Inc.

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in the United States and internationally. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain to help reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.

IDXX

IDEXX Laboratories Inc.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Latest ACHV

Latest IDXX